Pharma's new 'Berlin Declaration' seeks to reserve vaccines, therapeutics in production for low-income countries

As Pfizer/BioNTech and Moderna remain reluctant to share IP or provide tech transfer to expand the manufacture of their life-saving mRNA vaccines for Covid-19, the International Federation of Pharmaceutical Manufacturers & Associations on Tuesday unveiled a new plan, building off those Covid successes, to ensure more equitable pandemic preparedness.